| ZEFYLTI (FILGRASTIM) CURATEQ BIOLOGICS PRIVATE LIMITED
2201917 22 Apr 2022 | on 18 Sep 2024 | Class 005 Class 005 Pharmaceutical Products Medicinal, pharmaceutical and veterinary preparations, namely, prescription pharmaceutical preparation for use in stimulating white blood cell production; pharmaceutical preparations, namely, filgrastim for use in stimulating white blood cell production. | | | ZEFYLTI CURATEQ BIOLOGICS PRIVATE LIMITED
2190856 11 Mar 2022 | on 18 Sep 2024 | Class 005 Class 005 Pharmaceutical Products Medicinal, pharmaceutical and veterinary preparations, namely, prescription pharmaceutical preparation for use in stimulating white blood cell production; pharmaceutical preparations, namely, filgrastim for use in stimulating white blood cell production. | | | ZEFYOR JOHNSON & JOHNSON
1792808 22 Jul 2016 | on 26 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Human pharmaceutical preparations for the treatment of cardiovascular diseases; antivirals; anti-infectives; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human vaccines. | | | ZEFYANT ELI LILLY AND COMPANY
1339040 13 Mar 2007 | on 31 Mar 2010 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, namely Non-Hodgkins Lymphoma, Burkitts Lymphoma, Waldenstroms Macroglobulinemia, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, cancer, cardiovascular diseases, central nervous system diseases and disorders, namely anxiety disorders, depression; bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia, cognitive impairment associated with schizophrenia, diabetes, endocrine diseases and disorders, namely, type 1 diabetes mellitus and type 2 diabetes mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms, hot flashes, inflammation and inflammatory diseases and disorders, namely, rheumatoid arthritis, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimers disease, mild cognitive impairment, Parkinsons disease, obesity, pain, namely, chronic pain, neuropathic pain, non-neuropathic pain, non-inflammatory pain, inflammatory pain, visceral pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders, antipsychotic agents; and antidepressants. | |